We also investigated a possible correlation between BORIS levels in breast tumour tissues and clinical/pathological parameters: tumour stage, tumour grade, tumour size, ER status, PR status, HER-2 receptor status, lymph node metastasis, preoperative and post-operative chemotherapy, menopausal state and patient's age. This evidence concerns the gene PGR and breast neoplasm.